Formulation of lymphokines and method of use thereof for local or bath local and systemic control of proliferative cell disorders

Details for Australian Patent Application No. 2002312499 (hide)

Owner Protherics Salt Lake City, Inc.

Inventors Zentner, Gaylen M.; Samlowski, Wolfram; Baudys, Miroslav; Jurek, Maria

Agent FB Rice

Pub. Number AU-B-2002312499

PCT Number PCT/US02/18807

PCT Pub. Number WO2002/102309

Priority 60/298,594 14.06.01 US; 10/172,805 13.06.02 US

Filing date 14 June 2002

Wipo publication date 2 January 2003

Acceptance publication date 19 April 2007

International Classifications

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 60/298,594 14.06.01 US; 10/172,805 13.06.02 US

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002312499

15 January 2004 Amendment Made

  The nature of the amendment is: Amend the invention title to read Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders.

19 April 2007 Application Accepted

  Published as AU-B-2002312499

16 August 2007 Standard Patent Sealed

30 August 2007 Corrigenda

  Applications Accepted - Name Index Under the name Protherics Salt Lake City, Inc., application no. 2002312499, under INID (54), correct the title to read Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002312500-SOCKET FOR SEMICONDUCTOR PACKAGE

2002312498-METHODS AND SYSTEMS FOR SENDING SIDE-CHANNEL DATA DURING DATA INACTIVE PERIOD